Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00772018 · ClinicalTrials.gov registry record
Quality of Life and Symptom Management in Patients With Bladder Cancer
A clinical trial of Bladder Cancer, sponsored by David Latini.
- Completed
- Registry status
- 28
- Enrollment target
- 2
- Study locations
NCT00772018 is a study of Bladder Cancer that has completed, run by David Latini. The registered enrollment target is 28 participants, below the 12,754-participant average among 175 other Bladder Cancer trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00772018, a study of Bladder Cancer, has completed, sponsored by David Latini.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Learning about quality of life and symptom management in patients with bladder cancer may help doctors learn about the effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying of quality of life and symptom management in patients with bladder cancer.
Conditions Studied
Study Locations (2)
Texas
- Dan L. Duncan Cancer Center at Baylor College of Medicine - Houston
- Veterans Affairs Medical Center - Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00772018
The ClinicalTrials.gov registry entry for NCT00772018 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,754-participant average among 175 other Bladder Cancer trials with a reported enrollment target (100% lower). The listed sponsor is David Latini, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00772018 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00772018 about?
NCT00772018 is a clinical study titled "Quality of Life and Symptom Management in Patients With Bladder Cancer". RATIONALE: Learning about quality of life and symptom management in patients with bladder cancer may help doctors learn about the effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying of quality of life and symptom management in patients with bladder cancer.
What is the current status of trial NCT00772018?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2008-05. Estimated completion is 2010-09.
What conditions does trial NCT00772018 study?
This clinical trial studies the following conditions: Bladder Cancer.
Who is sponsoring clinical trial NCT00772018?
This trial is sponsored by David Latini, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00772018 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.